TAMPA, Fla. (Oct. 13, 2014) – Christine M. Walko, PharmD, research scientist at Moffitt Cancer Center, has been selected for induction as a Fellow of the American College of Clinical Pharmacy. The fellowship is awarded to those who have made lasting contributions in the field of clinical pharmacy practice and research.
“This is the highest designation in the clinical pharmacology field,” said Howard McLeod, PharmD, medical director of the DeBartolo Family Personalized Medicine Institute and senior member in the Department of Cancer Epidemiology. “Dr. Walko is an exceptional clinical scientist and a valuable member of the Moffitt team.
To be considered for fellowship, a candidate must receive nominations from American College of Clinical Pharmacy members, American College of Clinical Pharmacy fellows or Board of Regents members. The candidate must also have been in practice for at least 10 years.
Fellows will be honored at the American College of Clinical Pharmacy Annual Meeting Oct. 12-15 in Austin, Texas.
About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in Florida and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer since 1999. With more than 4,500 employees, Moffitt has an economic impact on Florida of nearly $1.6 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.